Blood pressure telemonitoring is useful to achieve blood pressure control in inadequately treated patients with arterial hypertension

Journal of Human Hypertension

Volumn 25, Issue 12, 2011, Pages 732-738

  Neumann, C L ^a   Menne, J ^b   Rieken, E M ^a   Fischer, N ^a   Weber, M H ^a   Haller, H ^b   Schulz, E G ^a  

^a Hypertension Care and Research Unit   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Antihypertensive agents; Home blood pressure; Irbesartan; Telemedicine; Telemonitoring; Treatment goals

Indexed keywords

IRBESARTAN;

ADULT; AGED; ALARM MONITORING; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; FEMALE; HIGH RISK PATIENT; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PULSE PRESSURE; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; TELEMONITORING;

ADULT; AGED; ALGORITHMS; ANTIHYPERTENSIVE AGENTS; BIPHENYL COMPOUNDS; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CIRCADIAN RHYTHM; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MONITORING, AMBULATORY; OFFICE VISITS; PHYSICIAN-PATIENT RELATIONS; TELEMEDICINE; TETRAZOLES; TIME FACTORS; TREATMENT OUTCOME;

EID: 81455127295     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/jhh.2010.119     Document Type: Article

References (33)

1. Meisinger C, Heier M, Volzke H, Lowel H, Mitusch R, Hense HW et al. Regional disparities of hypertension prevalence and management within Germany. J Hypertens 2006; 24(2): 293-299. (Pubitemid 43348240)
2. Wolf-Maier K, Cooper RS, Banegas JR, Giampaoli S, Hense HW, Joffres M et al. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA 2003; 289(18): 2363-2369. (Pubitemid 37430168)
3. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 2006; 367(9524): 1747-1757. (Pubitemid 43767064)
4. Lowel H, Meisinger C, Heier M, Hymer H, Alte D, Volzke H. [Epidemiology of hypertension in Germany. Selected results of population-representative crosssectional studies]. Dtsch Med Wochenschr 2006; 131(46): 2586-2591. (Pubitemid 44899498)
5. Erdine S, Aran SN. Current status of hypertension control around the world. Clin Exp Hypertens 2004; 26(7-8): 731-738. (Pubitemid 40129762)
6. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G et al. Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007; 25(6): 1105-1187 (Pubitemid 46924065)
7. Yakovlevitch M, Black HR. Resistant hypertension in a tertiary care clinic. Arch Intern Med 1991; 151(9): 1786-1792.
8. Parati G, Stergiou GS, Asmar R, Bilo G, de Leeuw P, Imai Y et al. European Society of Hypertension guidelines for blood pressure monitoring at home: a summary report of the Second International Consensus Conference on Home Blood Pressure Monitoring. J Hypertens 2008; 26(8): 1505-1526.
9. Pickering TG, Miller NH, Ogedegbe G, Krakoff LR, Artinian NT, Goff D. Call to action on use and reimbursement for home blood pressure monitoring: Executive Summary. A joint scientific statement from the American Heart Association, American Society of Hypertension, and Preventive Cardiovascular Nurses Association. J clin hypertens (Greenwich, Conn) 2008; 10(6): 467-476.
10. Hobbs FD, Erhardt L. Acceptance of guideline recommendations and perceived implementation of coronary heart disease prevention among primary care physicians in five European countries: the Reassessing European Attitudes about Cardiovascular Treatment (REACT) survey. Fam Pract 2002; 19(6): 596-604. (Pubitemid 35460642)
11. Parati G, Valentini M. Do we need out-of-office blood pressure in every patient? Curr Opin Cardiol 2007; 22(4): 321-328. (Pubitemid 46897284)
12. Mengden T, Hernandez Medina RM, Beltran B, Alvarez E, Kraft K, Vetter H. Reliability of reporting selfmeasured blood pressure values by hypertensive patients. Am J Hypertens 1998; 11(12): 1413-1417. (Pubitemid 29030304)
13. van der Hoeven NV, van den Born BJ, Cammenga M, van Montfrans GA. Poor adherence to home blood pressure measurement schedule. J Hypertens 2009; 27(2): 275-279.
14. Johnson KA, Partsch DJ, Rippole LL, McVey DM. Reliability of self-reported blood pressure measurements. Arch Intern Med 1999; 159(22): 2689-2693.
15. Krecke HJ, Lutkes P, Maiwald M. Patient assessment of self-measurement of blood pressure: results of a telephone survey in Germany. J Hypertens 1996; 14(3): 323-326.
16. Mengden T, Vetter H, Tisler A, Illyes M. Tele-monitoring of home blood pressure. Blood press monit 2001; 6(4): 185-189. (Pubitemid 33120929)
17. Pare G, Jaana M, Sicotte C. Systematic review of home telemonitoring for chronic diseases: the evidence base. J Am Med Inform Assoc 2007; 14(3): 269-277. (Pubitemid 46646987)
18. Rossing K, Schjoedt KJ, Jensen BR, Boomsma F, Parving HH. Enhanced renoprotective effects of ultrahigh doses of irbesartan in patients with type 2 diabetes and microalbuminuria. Kidney Int 2005; 68(3): 1190-1198. (Pubitemid 43246436)
19. Weinberg AJ, Zappe DH, Ramadugu R, Weinberg MS. Long-term safety of high-dose angiotensin receptor blocker therapy in hypertensive patients with chronic kidney disease. J Hypertens Suppl 2006; 24(1): S95-S99. (Pubitemid 44336830)
20. Marino MR, Langenbacher K, Ford NF, Uderman HD. Pharmacokinetics and pharmacodynamics of irbesartan in healthy subjects. J Clin Pharmacol 1998; 38(3): 246-255. (Pubitemid 28144930)
21. Reeves RA, Lin CS, Kassler-Taub K, Pouleur H. Dose-related efficacy of irbesartan for hypertension: an integrated analysis. Hypertension 1998; 31(6): 1311-1316. (Pubitemid 28248833)
22. Menne J, Farsang C, Deak L, Klebs S, Meier M, Handrock R et al. Valsartan in combination with lisinopril versus the respective high dose monotherapies in hypertensive patients with microalbuminuria: the VALERIA trial. J Hypertens 2008; 26(9): 1860-1867.
23. Elliott HL. Focus on the ONTARGET results. J Hypertens Suppl 2009; 27(2): S8-S10.
24. Giles T. ONTARGET for hypertension or not? Curr Hypertens Rep 2008; 10(4): 303-304.
25. Sengul AM, Altuntas Y, Kurklu A, Aydin L. Beneficial effect of lisinopril plus telmisartan in patients with type 2 diabetes, microalbuminuria and hypertension. Diabetes Res Clin Pract 2006; 71(2): 210-219. (Pubitemid 43112114)
26. Sudano I, Noll G. Dual blockade versus single blockade of the renin-angiotensin system in the light of ONTARGET. J Hypertens Suppl 2009; 27(2): S11-S14.
27. Rogers MA, Small D, Buchan DA, Butch CA, Stewart CM, Krenzer BE et al. Home monitoring service improves mean arterial pressure in patients with essential hypertension. A randomized, controlled trial. Ann Intern Med 2001; 134(11): 1024-1032. (Pubitemid 32488656)
28. Friedman RH, Kazis LE, Jette A, Smith MB, Stollerman J, Torgerson J et al. A telecommunications system for monitoring and counseling patients with hypertension. Impact on medication adherence and blood pressure control. Am J Hypertens 1996; 9(4 part 1): 285-292.
29. Pickering TG, Gerin W, Holland JK. Home blood pressure teletransmission for better diagnosis and treatment. Curr Hypertens Rep 1999; 1(6): 489-494.
30. Staessen JA, Thijs L, Fagard R, O'Brien ET, Clement D, de Leeuw PW et al. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic Hypertension in Europe Trial Investigators. Jama 1999; 282(6): 539-546. (Pubitemid 29380290)
31. Hollenberg NK, Parving HH, Viberti G, Remuzzi G, Ritter S, Zelenkofske S et al. Albuminuria response to very high-dose valsartan in type 2 diabetes mellitus. J Hypertens 2007; 25(9): 1921-1926. (Pubitemid 47356634)
32. Illyes M, Mengden T, Tisler A. The virtual hypertension clinic. Blood Press Monit 2002; 7(1): 67-68. (Pubitemid 34304057)
33. Vetter H, Mengden T, Kraft K. Verbesserung der langzeitkontrolle der arteriellen hypertonie mit blutdruckselbstmessung. Dtsch Arztebl 1998; 95(45): 2833.